The Week in Review: September 29 – October 6, 2017

Friday, October 6, 2017 News Recap: Liver Cancer Two studies on liver cancer in the news last week highlighted the global prevalence and causes of this terrible disease.  The first showed a direct correlation between excess weight and cancer occurrence (including liver cancer) – Cancers linked to excess weight make up 40% of all US diagnoses, study finds, while the second focussed on the global incidence of primary liver cancer. Hepatitis B virus wa...

Reactivation Rate of Hepatitis B in Inflammatory Arthritis Tx With DMARDs

It's not only DAAs than can reactivate HBV. In patients with inflammatory arthritis receiving disease-modifying antirheumatic drugs (DMARDs), rates of hepatitis B (HBV) reactivation differ between those whose disease is resolved and those with chronic HBV infection. Findings from the systematic review and meta-analysis were published in Arthritis Care & Research (Hoboken). Patients with chronic HBV generally have a 5-fold to 8-fold higher risk for HBV

The Week in Review: August 18 – August 25, 2017

Friday, August 25, 2017 News Recap: Public health issues Hep B risk warning: Tools used in procedures such as callus scraping and cutting toenails could become contaminated with the virus and remain contaminated because of the sterilization practices followed. Public health authorities in Owen Sound have identified a local foot care clinic as a potential source of hepatitis B and are warning patients – other than orthotics patients – to consult a doc...

Public health issues Hep B risk warning

Tools used in procedures such as callus scraping and cutting toenails could become contaminated with the virus and remain contaminated because of the sterilization practices followed. Public health authorities have identified a local foot care clinic as a potential source of hepatitis B and are warning patients – other than orthotics patients – to consult a doctor about getting tested for this disease. Grey Bruce Health Unit issued a public advisory Tu

Gilead Receives Approval in Canada for VEMLIDY™ (Tenofovir Alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection

MISSISSAUGA, ON, June 19, 2017 /CNW/ - Gilead Sciences Canada, Inc. (Gilead Canada) today announced that Health Canada has granted a Notice of Compliance (NOC) for VEMLIDY™ (tenofovir alafenamide, TAF) 25mg tablets, a once-daily treatment for adults with chronic hepatitis B virus (HBV) infection with compensated liver disease. – VEMLIDY is a Once-Daily Treatment that Demonstrated Similar Efficacy with Improved Renal and Bone Laboratory Safety Parameters C

Couldn’t Attend World Hepatitis Summit? View All Presentations Here!

Message from Organizers of World Hepatitis Summit 2015 in Glasgow, Scotland Sept. 2-4, 2015: "On behalf of the World Hepatitis Summit partner organisations, we, the Summit Organising Committee, would like to thank you for your attendance and important role at the Summit. The Summit had over 600 delegates in attendance through the week representing over 90 countries – it truly was a global event. The feedback so far has been very positive and we reali

Sign TORONTO DECLARATION on VIRAL HEPATITIS!

The TORONTO DECLARATION: STRATEGIES TO CONTROL AND ELIMINATE VIRAL HEPATITIS GLOBALLY resulted from Toronto's Nov. 5-6, 2014 "First International Meeting on Hepatitis Cure & Eradication", hosted by Virology Education (http://www.virology-education.com). The FULL DECLARATION is printed BELOW (link: http://www.infectiousdiseasesonline.com/wp-content/uploads/2014/11/toronto_declaration_v1.0-final_logo.pdf). To ADD YOUR NAME to the Toronto Declaratio...

World Health Organization VIRAL HEPATITIS Resolution passes

Read the unanimous UN/WHO resolution in full here: http://apps.who.int/gb/ebwha/pdf_files/EB134/B134_R18-en.pdf From IP-Watch article: "The resolution asks states to consider using the flexibilities endorsed in the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) to promote access to specific pharmaceutical products. The director general is also asked to provide necessary technical support to countries, in

WORLD HEPATITIS DAY 2013-British Columbia!

For more information about World Hepatitis Day 2013 activities in British Columbia, click on the city name. IF YOU DON'T SEE YOUR CITY OR NEAREST TOWN LISTED, LET US KNOW and we will put you in contact with the nearest organization in your area which can give you information or support. Hopefully next year, there will be a hepatitis awareness event in every part of British Columbia! ABBOTSFORD CAMPBELL RIVER COURTENAY GRAND FORKS NANAIMO NELSON SMITHERS SU

FREE: Most Current Statistics, Research, and Data about Hepatitis in Canada

The most current statistics, research, and data about hepatitis B and C, as well as other liver diseases, can be found in the recent report, Liver Disease in Canada: A Crisis in the Making: An Assessment of Liver Disease in Canada Published by the Canadian Liver Foundation in March, 2013. Dr. Morris Sherman (MB.BCh, PhD, FRCP(C)), et al. Download this ENTIRE important report in PDF format from:http://www.liver.ca/files/PDF/Liver_Disease_Report_2013/Liver_D